Real-world long-term survival after non-emergent percutaneous coronary intervention to unprotected left main coronary artery — From the Melbourne Interventional Group (MIG) registry-Reference-Cited by-同舟云学术

Real-world long-term survival after non-emergent percutaneous coronary intervention to unprotected left main coronary artery — From the Melbourne Interventional Group (MIG) registry

Published:2023-07 Issue: Volume: Page:
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Gin Julian,Yeoh Julian,Hamilton Garry,Ajani Andrew,Dinh Diem,Brennan Angela,Reid Christopher M.,Freeman Melanie,Oqueli Ernesto,Hiew Chin,Stub Dion,Chan William,Picardo Sandra,Yudi Matias,Horrigan Mark,Farouque Omar,Clark David

Funder

Austin Health

National Health and Medical Research Council

National Heart Foundation of Australia

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference33 articles.

1. Management of left main coronary artery disease;Ramadan;J Am Heart Assoc.,2018

2. Everolimus-eluting stents or bypass surgery for left Main coronary artery disease;Stone;N Engl J Med,2016

3. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial;Makikallio;Lancet.,2016

4. Randomized trial of stents versus bypass surgery for left main coronary artery disease;Park;N Engl J Med.,2011

5. Writing Committee M, Lawton JS, Tamis-Holland JE, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79(2):197-215. doi:https://doi.org/10.1016/j.jacc.2021.09.005.